Drug Profile
Research programme: antiviral vaccines - Paladin Labs
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator ViRexx Medical Corp
- Developer Endo International
- Class Hepatitis B vaccines; Hepatitis C vaccines; Influenza virus vaccines; Viral hepatitis vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hepatitis B; Hepatitis C; Influenza virus infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Hepatitis-B in Canada
- 16 Jul 2016 No recent reports of development identified for preclinical development in Hepatitis-C in Canada
- 16 Jul 2016 No recent reports of development identified for preclinical development in Influenza-virus-infections(Prevention) in Canada